Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people with relapsed and refractory Hodgkin lymphoma receive brentuximab vedotin through the NHS.
The number of people who received brentuximab vedotin through the National Health Service is not collected centrally.